{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:09:26Z","timestamp":1787843366128,"version":"build-2784847793"},"reference-count":44,"publisher":"Harborside Press, LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    As one of the 10 most common cancers in the United States, bladder cancer is the most expensive cancer to treat. Most bladder cancers (70%\u201380%) are diagnosed at early stages as non\u2013muscle-invasive bladder cancer (NMIBC), which can be removed. However, 50% to 80% of NMIBC recurs within 5 years, and 15% to 30% progresses with poor survival. Besides life-long surveillance, current treatment is limited. Preclinical and epidemiologic evidence suggest that dietary isothiocyanates (ITCs) in cruciferous vegetables (Cruciferae) could be a noninvasive and cost-effective strategy to improve NMIBC prognosis. Yet, a Cruciferae intervention that increases ITC exposure in NMIBC survivors has not been tested. Thus, the primary aim of this study was to test the effect of a Cruciferae intervention on urinary ITC levels and Cruciferae intake in NMIBC survivors.\n                    <jats:bold>Patients and Methods:<\/jats:bold>\n                    We conducted a 2-arm, double-blinded, randomized controlled trial to test the efficacy of a Cruciferae intervention against a general fruit and vegetable intervention (control) for NMIBC survivors. Both 6-month interventions consisted of mailed educational materials, a live call with staff to review the materials, and 11 interactive voice response calls. We anticipated that our Cruciferae intervention (Power to Redefine Your Health [POW-R Health]) would increase Cruciferae intake to 1 cup\/day (secondary outcome), thus raising urinary ITC levels to 10 \u00b5M (primary outcome) from baseline to 6-month follow-up.\n                    <jats:bold>Results:<\/jats:bold>\n                    We randomized 49 patients with NMIBC diagnosed in 2018 through 2019, and retained 42 patients at 6-month follow-up. The treatment group reported 0.94 cups (95% CI, 0.24\u20131.65;\n                    <jats:italic>P<\/jats:italic>\n                    =.010) higher Cruciferae intake (treatment, 1.37 \u00b1 1.19 cups vs control, 0.56 \u00b1 0.72 cups) and increased urinary ITC levels by 11.1 \u03bcmol\/g creatinine (treatment, 26.2 \u00b1 20.9 vs control, 7.8 \u00b1 11.5;\n                    <jats:italic>P<\/jats:italic>\n                    =.027) at 6-month follow-up compared with the control group.\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    Our dietary intervention is the first to significantly increase Cruciferae intake and urinary ITC levels in NMIBC survivors, demonstrating an increase in ITC to levels that significantly decrease risk of disease-specific survival. A future randomized controlled trial testing POW-R Health on bladder cancer recurrence and progression is warranted. If proven to improve bladder cancer outcomes, our intervention has the potential to be a noninvasive, cost-effective, easily accessible way for NBMIC survivors to improve their bladder cancer prognosis.\n                  <\/jats:p>","DOI":"10.6004\/jnccn.2023.7086","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T16:36:36Z","timestamp":1708965396000},"source":"Crossref","is-referenced-by-count":6,"title":["Outcomes of a Dietary Intervention to Reduce Bladder Cancer Recurrence and Progression in Survivors of Non\u2013Muscle-Invasive Bladder Cancer"],"prefix":"10.6004","volume":"22","author":[{"given":"Karen H. Kim","family":"Yeary","sequence":"first","affiliation":[{"name":"Roswell Park Comprehensive Cancer Center, Buffalo, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yu","sequence":"additional","affiliation":[{"name":"Roswell Park Comprehensive Cancer Center, Buffalo, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret Gates","family":"Kuliszewski","sequence":"additional","affiliation":[{"name":"New York State Cancer Registry, Albany, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[{"name":"Roswell Park Comprehensive Cancer Center, Buffalo, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"McCann","sequence":"additional","affiliation":[{"name":"Roswell Park Comprehensive Cancer Center, Buffalo, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Pratt","sequence":"additional","affiliation":[{"name":"Roswell Park Comprehensive Cancer Center, Buffalo, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances G.","family":"Saad-Harfouche","sequence":"additional","affiliation":[{"name":"Roswell Park Comprehensive Cancer Center, Buffalo, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinian","family":"Wang","sequence":"additional","affiliation":[{"name":"Roswell Park Comprehensive Cancer Center, Buffalo, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikia","family":"Clark","sequence":"additional","affiliation":[{"name":"Roswell Park Comprehensive Cancer Center, Buffalo, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Wang","sequence":"additional","affiliation":[{"name":"Roswell Park Comprehensive Cancer Center, Buffalo, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"DiCarlo","sequence":"additional","affiliation":[{"name":"Roswell Park Comprehensive Cancer Center, Buffalo, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[{"name":"Roswell Park Comprehensive Cancer Center, Buffalo, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","reference":[{"key":"B1","series-title":"Eur J Epidemiol","first-page":"811","article-title":"Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses","volume":"31","author":"Al-Zalabani AH","year":"2016","unstructured":"Al-Zalabani AH, Stewart KF, Wesselius A,  Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses. Eur J Epidemiol 2016;31:811\u2013851."},{"key":"B2","series-title":"CA Cancer J Clin","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel RL","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7\u201334."},{"key":"B3","series-title":"Expert Rev Anticancer Ther","first-page":"467","article-title":"Tackling non-muscle invasive bladder cancer in the clinic","volume":"17","author":"Woldu SL","year":"2017","unstructured":"Woldu SL, \u015eanli \u00d6, Lotan Y. Tackling non-muscle invasive bladder cancer in the clinic. Expert Rev Anticancer Ther 2017;17:467\u2013480."},{"key":"B4","series-title":"Lancet","first-page":"2796","article-title":"Bladder cancer","volume":"388","author":"Kamat AM","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA,  Bladder cancer. Lancet 2016;388:2796\u20132810."},{"key":"B5","series-title":"J Urol","first-page":"1823","article-title":"The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years","volume":"153","author":"Holm\u00e4ng S","year":"1995","unstructured":"Holm\u00e4ng S, Hedelin H, Anderstr\u00f6m C,  The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 1995;153:1823\u20131826; discussion 1826\u20131827."},{"key":"B6","series-title":"Rev Urol","first-page":"23","article-title":"Bladder Cancer Academy 2019 selected summaries","volume":"21","author":"Schulster M","year":"2019","unstructured":"Schulster M. Bladder Cancer Academy 2019 selected summaries. Rev Urol 2019;21:23\u201328."},{"key":"B7","series-title":"Eur Urol","first-page":"738","article-title":"Predicting response to intravesical bacillus Calmette-Gu\u00e9rin immunotherapy: are we there yet? A systematic review","volume":"73","author":"Kamat AM","year":"2018","unstructured":"Kamat AM, Li R, O\u2019Donnell MA,  Predicting response to intravesical bacillus Calmette-Gu\u00e9rin immunotherapy: are we there yet? A systematic review. Eur Urol 2018;73:738\u2013748."},{"key":"B8","series-title":"Adv Urol","first-page":"421709","article-title":"Surveillance and treatment of non-muscle-invasive bladder cancer in the USA","volume":"2012","author":"Barocas DA","year":"2012","unstructured":"Barocas DA, Globe DR, Colayco DC,  Surveillance and treatment of non-muscle-invasive bladder cancer in the USA. Adv Urol 2012;2012:421709."},{"key":"B9","series-title":"Urology","first-page":"549","article-title":"Clinical model of lifetime cost of treating bladder cancer and associated complications","volume":"68","author":"Avritscher EB","year":"2006","unstructured":"Avritscher EB, Cooksley CD, Grossman HB,  Clinical model of lifetime cost of treating bladder cancer and associated complications. Urology 2006;68:549\u2013553."},{"key":"B10","series-title":"Pharmacoeconomics","first-page":"1315","article-title":"The health economics of bladder cancer: a comprehensive review of the published literature","volume":"21","author":"Botteman MF","year":"2003","unstructured":"Botteman MF, Pashos CL, Redaelli A,  The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 2003;21:1315\u20131330."},{"key":"B11","series-title":"Cancer Nurs","first-page":"E21","article-title":"Quality of life in non-muscle-invasive bladder cancer survivors: a systematic review","volume":"42","author":"Jung A","year":"2019","unstructured":"Jung A, Nielsen ME, Crandell JL,  Quality of life in non-muscle-invasive bladder cancer survivors: a systematic review. Cancer Nurs 2019;42:E21\u201333."},{"key":"B12","series-title":"Cancer Epidemiol Biomarkers Prev","first-page":"1806","article-title":"Intake of cruciferous vegetables modifies bladder cancer survival","volume":"19","author":"Tang L","year":"2010","unstructured":"Tang L, Zirpoli GR, Guru K,  Intake of cruciferous vegetables modifies bladder cancer survival. Cancer Epidemiol Biomarkers Prev 2010;19:1806\u20131811."},{"key":"B13","series-title":"Cancer Epidemiol Biomarkers Prev","first-page":"938","article-title":"Consumption of raw cruciferous vegetables is inversely associated with bladder cancer risk","volume":"17","author":"Tang L","year":"2008","unstructured":"Tang L, Zirpoli GR, Guru K,  Consumption of raw cruciferous vegetables is inversely associated with bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2008;17:938\u2013944."},{"key":"B14","series-title":"Mol Cancer Ther","first-page":"935","article-title":"Potent activation of mitochondria-mediated apoptosis and arrest in S and M phases of cancer cells by a broccoli sprout extract","volume":"5","author":"Tang L","year":"2006","unstructured":"Tang L, Zhang Y, Jobson HE,  Potent activation of mitochondria-mediated apoptosis and arrest in S and M phases of cancer cells by a broccoli sprout extract. Mol Cancer Ther 2006;5:935\u2013944."},{"key":"B15","series-title":"Mol Cancer Ther","first-page":"1250","article-title":"Mitochondria are the primary target in isothiocyanate-induced apoptosis in human bladder cancer cells","volume":"4","author":"Tang L","year":"2005","unstructured":"Tang L, Zhang Y. Mitochondria are the primary target in isothiocyanate-induced apoptosis in human bladder cancer cells. Mol Cancer Ther 2005;4:1250\u20131259."},{"key":"B16","series-title":"J Nutr","first-page":"2004","article-title":"Dietary isothiocyanates inhibit the growth of human bladder carcinoma cells","volume":"134","author":"Tang L","year":"2004","unstructured":"Tang L, Zhang Y. Dietary isothiocyanates inhibit the growth of human bladder carcinoma cells. J Nutr 2004;134:2004\u20132010."},{"key":"B17","series-title":"Curr Drug Metab","first-page":"193","article-title":"Isothiocyanates in the chemoprevention of bladder cancer","volume":"5","author":"Tang L","year":"2004","unstructured":"Tang L, Zhang Y. Isothiocyanates in the chemoprevention of bladder cancer. Curr Drug Metab 2004;5:193\u2013201."},{"key":"B18","series-title":"Anticancer Drugs","first-page":"297","article-title":"The principal urinary metabolites of dietary isothiocyanates, N-acetylcysteine conjugates, elicit the same anti-proliferative response as their parent compounds in human bladder cancer cells","volume":"17","author":"Tang L","year":"2006","unstructured":"Tang L, Li G, Song L,  The principal urinary metabolites of dietary isothiocyanates, N-acetylcysteine conjugates, elicit the same anti-proliferative response as their parent compounds in human bladder cancer cells. Anticancer Drugs 2006;17:297\u2013305."},{"key":"B19","series-title":"Cancer Res","first-page":"1593","article-title":"Inhibition of urinary bladder carcinogenesis by broccoli sprouts","volume":"68","author":"Munday R","year":"2008","unstructured":"Munday R, Mhawech-Fauceglia P, Munday CM,  Inhibition of urinary bladder carcinogenesis by broccoli sprouts. Cancer Res 2008;68:1593\u20131600."},{"key":"B20","series-title":"J Biol Chem","first-page":"32259","article-title":"Allyl isothiocyanate arrests cancer cells in mitosis, and mitotic arrest in turn leads to apoptosis via Bcl-2 protein phosphorylation","volume":"286","author":"Geng F","year":"2011","unstructured":"Geng F, Tang L, Li Y,  Allyl isothiocyanate arrests cancer cells in mitosis, and mitotic arrest in turn leads to apoptosis via Bcl-2 protein phosphorylation. J Biol Chem 2011;286:32259\u201332267."},{"key":"B21","series-title":"Carcinogenesis","first-page":"281","article-title":"Inhibition of bladder cancer development by allyl isothiocyanate","volume":"31","author":"Bhattacharya A","year":"2010","unstructured":"Bhattacharya A, Tang L, Li Y,  Inhibition of bladder cancer development by allyl isothiocyanate. Carcinogenesis 2010;31:281\u2013286."},{"key":"B22","series-title":"J Sci Food Agric","first-page":"1477","article-title":"Effects of fertilisation on the allyl isothiocyanate profile of above-ground tissues of New Zealand-grown wasabi","volume":"82","author":"Sultana T","year":"2002","unstructured":"Sultana T, Savage GP, McNeil DL,  Effects of fertilisation on the allyl isothiocyanate profile of above-ground tissues of New Zealand-grown wasabi. J Sci Food Agric 2002;82:1477\u20131482."},{"key":"B23","series-title":"Cancer Prev Res (Phila)","first-page":"971","article-title":"A randomized pilot trial of dietary modification for the chemoprevention of noninvasive bladder cancer: the dietary intervention in bladder cancer study","volume":"6","author":"Parsons JK","year":"2013","unstructured":"Parsons JK, Pierce JP, Natarajan L,  A randomized pilot trial of dietary modification for the chemoprevention of noninvasive bladder cancer: the dietary intervention in bladder cancer study. Cancer Prev Res (Phila) 2013;6:971\u2013978."},{"key":"B24","series-title":"Urol Oncol","first-page":"380","article-title":"Lifestyle and nutritional modifiable factors in the prevention and treatment of bladder cancer","volume":"37","author":"Kwan ML","year":"2019","unstructured":"Kwan ML, Garren B, Nielsen ME,  Lifestyle and nutritional modifiable factors in the prevention and treatment of bladder cancer. Urol Oncol 2019;37:380\u2013386."},{"key":"B25","series-title":"Food Sci Nutr","first-page":"5673","article-title":"Effects of cooking methods on total isothiocyanate yield from cruciferous vegetables","volume":"8","author":"Wang Z","year":"2020","unstructured":"Wang Z, Kwan ML, Pratt R,  Effects of cooking methods on total isothiocyanate yield from cruciferous vegetables. Food Sci Nutr 2020;8:5673\u20135682."},{"key":"B26","series-title":"J Funct Foods","first-page":"1996","article-title":"Total isothiocyanate yield from raw cruciferous vegetables commonly consumed in the United States","volume":"5","author":"Tang L","year":"2013","unstructured":"Tang L, Paonessa JD, Zhang Y,  Total isothiocyanate yield from raw cruciferous vegetables commonly consumed in the United States. J Funct Foods 2013;5:1996\u20132001."},{"key":"B27","series-title":"Cochrane Database Syst Rev","first-page":"CD011287","article-title":"Dietary interventions for adult cancer survivors","volume":"2019","author":"Burden S","year":"2019","unstructured":"Burden S, Jones DJ, Sremanakova J,  Dietary interventions for adult cancer survivors. Cochrane Database Syst Rev 2019;2019:CD011287."},{"key":"B28","series-title":"Nutrients","first-page":"348","article-title":"The role of diet in prognosis among cancer survivors: a systematic review and meta-analysis of dietary patterns and diet interventions","volume":"14","author":"Castro-Espin C","year":"2022","unstructured":"Castro-Espin C, Agudo A. The role of diet in prognosis among cancer survivors: a systematic review and meta-analysis of dietary patterns and diet interventions. Nutrients 2022;14:348."},{"key":"B29","series-title":"Nutrients","first-page":"612","article-title":"Systematic review of behaviour change theories implementation in dietary interventions for people who have survived cancer","volume":"13","author":"Sremanakova J","year":"2021","unstructured":"Sremanakova J, Sowerbutts AM, Todd C,  Systematic review of behaviour change theories implementation in dietary interventions for people who have survived cancer. Nutrients 2021;13:612."},{"key":"B30","series-title":"Cancer Epidemiol Biomarkers Prev","first-page":"752","article-title":"Feasibility and acceptability of a web-based dietary intervention with text messages for colorectal cancer: a randomized pilot trial","volume":"29","author":"Van Blarigan EL","year":"2020","unstructured":"Van Blarigan EL, Kenfield SA, Chan JM,  Feasibility and acceptability of a web-based dietary intervention with text messages for colorectal cancer: a randomized pilot trial. Cancer Epidemiol Biomarkers Prev 2020;29:752\u2013760."},{"key":"B31","series-title":"BMC Cancer","first-page":"298","article-title":"A randomized controlled trial of physical activity, dietary habit, and distress management with the Leadership and Coaching for Health (LEACH) program for disease-free cancer survivors","volume":"17","author":"Yun YH","year":"2017","unstructured":"Yun YH, Kim YA, Lee MK,  A randomized controlled trial of physical activity, dietary habit, and distress management with the Leadership and Coaching for Health (LEACH) program for disease-free cancer survivors. BMC Cancer 2017;17:298."},{"key":"B32","series-title":"Int J Behav Nutr Phys Act","first-page":"19","article-title":"Long-term effects of a web-based cancer aftercare intervention on moderate physical activity and vegetable consumption among early cancer survivors: a randomized controlled trial","volume":"14","author":"Kanera IM","year":"2017","unstructured":"Kanera IM, Willems RA, Bolman CA,  Long-term effects of a web-based cancer aftercare intervention on moderate physical activity and vegetable consumption among early cancer survivors: a randomized controlled trial. Int J Behav Nutr Phys Act 2017;14:19."},{"key":"B33","series-title":"J Clin Oncol","first-page":"3465","article-title":"Lifestyle intervention development study to improve physical function in older adults with cancer: outcomes from Project LEAD","volume":"24","author":"Demark-Wahnefried W","year":"2006","unstructured":"Demark-Wahnefried W, Clipp EC, Morey MC,  Lifestyle intervention development study to improve physical function in older adults with cancer: outcomes from Project LEAD. J Clin Oncol 2006;24:3465\u20133473."},{"key":"B34","series-title":"J Clin Oncol","first-page":"2709","article-title":"Main outcomes of the FRESH START trial: a sequentially tailored, diet and exercise mailed print intervention among breast and prostate cancer survivors","volume":"25","author":"Demark-Wahnefried W","year":"2007","unstructured":"Demark-Wahnefried W, Clipp EC, Lipkus IM,  Main outcomes of the FRESH START trial: a sequentially tailored, diet and exercise mailed print intervention among breast and prostate cancer survivors. J Clin Oncol 2007;25:2709\u20132718."},{"key":"B35","series-title":"JAMA","first-page":"1883","article-title":"Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: a randomized controlled trial","volume":"301","author":"Morey MC","year":"2009","unstructured":"Morey MC, Snyder DC, Sloane R,  Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: a randomized controlled trial. JAMA 2009;301:1883\u20131891."},{"key":"B36","series-title":"J Clin Oncol","first-page":"2313","article-title":"Effects of a telephone-delivered multiple health behavior change intervention (CanChange) on health and behavioral outcomes in survivors of colorectal cancer: a randomized controlled trial","volume":"31","author":"Hawkes AL","year":"2013","unstructured":"Hawkes AL, Chambers SK, Pakenham KI,  Effects of a telephone-delivered multiple health behavior change intervention (CanChange) on health and behavioral outcomes in survivors of colorectal cancer: a randomized controlled trial. J Clin Oncol 2013;31:2313\u20132321."},{"key":"B37","series-title":"JAMA","first-page":"140","article-title":"Effect of a behavioral intervention to increase vegetable consumption on cancer progression among men with early-stage prostate cancer: the MEAL randomized clinical trial","volume":"323","author":"Parsons JK","year":"2020","unstructured":"Parsons JK, Zahrieh D, Mohler JL,  Effect of a behavioral intervention to increase vegetable consumption on cancer progression among men with early-stage prostate cancer: the MEAL randomized clinical trial. JAMA 2020;323:140\u2013148."},{"key":"B38","series-title":"JMIR Cancer","first-page":"e32291","article-title":"Cruciferous vegetable intervention to reduce the risk of cancer recurrence in non-muscle-invasive bladder cancer survivors: development using a systematic process","volume":"8","author":"Yeary KHK","year":"2022","unstructured":"Yeary KHK, Clark N, Saad-Harfouche F,  Cruciferous vegetable intervention to reduce the risk of cancer recurrence in non-muscle-invasive bladder cancer survivors: development using a systematic process. JMIR Cancer 2022;8:e32291."},{"key":"B39","unstructured":"New York State. NYS cancer registry and cancer statistics. Accessed August 10, 2023. Available at: https:\/\/www.health.ny.gov\/statistics\/cancer\/registry\/"},{"key":"B40","unstructured":"US Department of Agriculture. Dietary guidelines for Americans, 2020\u20132025. Accessed August 5, 2023. Available at: https:\/\/www.dietaryguidelines.gov\/sites\/default\/files\/2020-12\/Dietary_Guidelines_for_Americans_2020-2025.pdf"},{"key":"B41","series-title":"CA Cancer J Clin","first-page":"230","article-title":"American Cancer Society nutrition and physical activity guideline for cancer survivors","volume":"72","author":"Rock CL","year":"2022","unstructured":"Rock CL, Thomson CA, Sullivan KR,  American Cancer Society nutrition and physical activity guideline for cancer survivors. CA Cancer J Clin 2022;72:230\u2013262."},{"key":"B42","series-title":"J Am Diet Assoc","first-page":"631","article-title":"Cruciferous vegetable intake questionnaire improves cruciferous vegetable intake estimates","volume":"107","author":"Thomson CA","year":"2007","unstructured":"Thomson CA, Newton TR, Graver EJ,  Cruciferous vegetable intake questionnaire improves cruciferous vegetable intake estimates. J Am Diet Assoc 2007;107:631\u2013643."},{"key":"B43","unstructured":"Nutrition Data System for Research (NDSR). Accessed August 5, 2023. Available at: https:\/\/www.ncc.umn.edu\/products\/"},{"key":"B44","series-title":"Anal Biochem","first-page":"100","article-title":"Spectroscopic quantitation of organic isothiocyanates by cyclocondensation with vicinal dithiols","volume":"205","author":"Zhang Y","year":"1992","unstructured":"Zhang Y, Cho CG, Posner GH,  Spectroscopic quantitation of organic isothiocyanates by cyclocondensation with vicinal dithiols. Anal Biochem 1992;205:100\u2013107."}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/22\/2\/article-e237086.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/22\/2\/article-e237086.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/22\/2\/article-e237086.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T15:35:52Z","timestamp":1710776152000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/22\/2\/article-e237086.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":44,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2023.7086","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}